Gilead's twice-yearly PrEP drug is cleared by FDA Gilead has FDA approval for a twice-yearly PrEP drug, but could proposed cuts to US funding for HIV prevention programmes hinder its take-up?

#PrEP #PrEP #FDA #GileadSciences #HIV #USA #preexposureprophylaxis #PrEP #HIVpreexposureprophylaxis #Yeztugo #phase3trials #PURPOSE1 #PURPOSE2 #HIVprevention #Truvada #PrEPmarket #emtricitabinetenofoviralafenamide #PrEPusers #HIVfunding #Prep4All
pharmaphorum.com/news/gileads...

This annual shot might protect against HIV infections Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Lenacapavir: annual shot might protect against HIV infection
www.technologyreview.com/2025/03/14/1...

[Dec 2024] Breakthrough of year could end HIV pandemic
mastodon.social/@persagen/11...
en.wikipedia.org/wiki/Lenacap...

#HIV #AIDS #prophylaxis #lenacapavir
#GileadScience #PURPOSE1 #PURPOSE2

#CROI2025

Data on Adolescents from the #purpose1 study

No significant differences in PK of #Lenacapavir between adult women and #adolescents.

Appears safe and well tolerated

#IDsky #HIVsky

A drawing by Keith Haring. A heart shape on a white background, which is made up of dancing figures, drawn in black. Each figure has a small red heart outline on their chest.

#Lenacapavir for #PrEP

Applications submitted to @ema.europa.eu for EU and global use:

i-base.info/htb/50208

Together #PURPOSE1 and #PURPOSE2 results showed 99% efficacy. Len for PrEP could play a unique role in #HIVprevention globally.

#PrEPaccess